Alexza Pharmaceuticals Inc
ALXA
ALXA was delisted on the 16th of June, 2016.
45 hedge funds and large institutions have $29.6M invested in Alexza Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 2 closing their positions.
982% more call options, than puts
Call options by funds: $5.37M | Put options by funds: $496K
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
73% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 11
10% more funds holding
Funds holding: 41 → 45 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less capital invested
Capital invested by funds: $30.7M → $29.6M (-$1.09M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$1.14M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$159K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$134K |
| 4 |
Millennium Management
New York
|
+$113K |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
+$82K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VM
VHCP Management
New York
|
-$652K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$169K |
| 3 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$133K |
| 4 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
-$78K |
| 5 |
Goldman Sachs
New York
|
-$57.7K |
ALXA Hedge Fund Activity: Q1 2014 in Review
45 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Alexza Pharmaceuticals Inc (ALXA) for Q1 2014, worth a combined $29.6M — down 3.5% from $30.7M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new ALXA positions and 2 closed out — a net gain of 4 holders — while 19 added to existing stakes and 11 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $1.14M. The largest seller was VHCP Management, cutting an estimated $652K.
- 45 institutional investors held Alexza Pharmaceuticals Inc (ALXA) as of Q1 2014, up from 41 in Q4 2013.
- Funds reported $29.6M of Alexza Pharmaceuticals Inc stock for Q1 2014, down 3.5% quarter-over-quarter.
- 6 funds opened new Alexza Pharmaceuticals Inc positions in Q1 2014 and 2 closed out, a net change of +4 holders.
- The largest Alexza Pharmaceuticals Inc buyer in Q1 2014 was Morgan Stanley, an estimated $1.14M added.
- The largest Alexza Pharmaceuticals Inc seller in Q1 2014 was VHCP Management, an estimated $652K sold.
Based on aggregated 13F filings for Q1 2014.